Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model

<p>Abstract</p> <p>Background</p> <p>The treatment paradigm in advanced renal cell carcinoma (RCC) has changed in the recent years. Sunitinib has been established as a new standard for first-line therapy. We studied the prognostic significance of baseline characteristics and we compared the risk str...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Christodoulou Christos, Skolarikos Andreas, Xanthakis Ioannis, Stravodimos Kostas, Anastasiou Ioannis, Kontovinis Loukas, Andreadis Charalambos, Papazisis Kostas, Timotheadou Eleni, Malettou Lia, Lainakis George, Lampaki Sofia, Karadimou Alexandra, Bamias Aristotelis, Syrigos Kostas, Papandreou Christos, Razi Evangelia, Dafni Urania, Fountzilas George, Dimopoulos Meletios A
Format:	Artigo
Sprog:	Inglês
Udgivet:	BMC 2010-02-01
Serier:	BMC Cancer
Online adgang:	http://www.biomedcentral.com/1471-2407/10/45
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!